Source:http://linkedlifedata.com/resource/pubmed/id/14703930
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2004-1-5
|
pubmed:abstractText |
Based on the results achieved in single human hand transplantations, we decided to perform the first double hand transplantation with a conventional immunosuppressive protocol in a patient with a high potential for functional recovery. Two years after transplantation the efficacy and the safety of this immunosuppressive protocol are evaluated. The recipient was a 33-yr-old man suffering from a traumatic amputation of both hands in 1996. Five HLA-A, -B, and -DR mismatches were present with the donor; T and B cell cross-match was negative. Immunosuppressive protocol included tacrolimus, prednisone, mycophenolate mofetil and, for induction, antithymocyte globulins and then anti CD25 monoclonal antibody. Reconstitution of lymphocyte populations proceeded normally. Neither anti-HLA antibodies nor chimerism in peripheral blood were detected. Two episodes of acute rejection characterized by maculopapular lesions occurred on days 53 and 82 after transplantation. Skin biopsies revealed a dermal lymphocytic infiltrate. Both episodes were completely and rapidly reversed by topical clobetasol and increased systemic corticosteroid therapy. The only side-effects related to treatment were reversible serum sickness and hyperglycemia. No infectious complications and malignancies occurred. No signs of graft-versus-host disease have been detected. This case of double hand transplantation shows that conventional immunosuppression is effective and safe to ensure survival and functional recovery of the grafted limb.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0902-0063
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
455-60
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14703930-Adult,
pubmed-meshheading:14703930-Amputation, Traumatic,
pubmed-meshheading:14703930-Graft Rejection,
pubmed-meshheading:14703930-Graft Survival,
pubmed-meshheading:14703930-Hand,
pubmed-meshheading:14703930-Hand Injuries,
pubmed-meshheading:14703930-Humans,
pubmed-meshheading:14703930-Immunosuppressive Agents,
pubmed-meshheading:14703930-Male,
pubmed-meshheading:14703930-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
First human double hand transplantation: efficacy of a conventional immunosuppressive protocol.
|
pubmed:affiliation |
Service de Chirurgie de Transplantation, Hôpital Edouard Herriot, Lyon, France.
|
pubmed:publicationType |
Journal Article,
Case Reports
|